-
44% of Life Science Professionals Already Using or Experimenting with AI and Deep Learning, Finds Su(1)
Jan 16, 2018, 12:00 PM by Michael CroftBOSTON, MA - Jan 9, 2018 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is calling on the pharmaceutical and technology industries to support greater collaboration around Artificial Intelligence (AI) in pharmaceutical R&DFull story -
Howard Jacob Leaving HudsonAlpha For AbbVie
Jan 16, 2018, 09:10 AM by Michael CroftFull storyBio-IT World | Less than three years after leaving the Medical College of Wisconsin for the HudsonAlpha Institute in Huntsville, Alabama, Howard Jacob is starting today as the Vice President of the Genomic Research Center at AbbVie.
-
Aalto Bio Reagents Announces Availability of Mouse Monoclonal Antibody to Helicobacter Pylori Flagellin for Diagnostic Testing
Jan 16, 2018, 07:37 AM by Michael CroftDUBLIN, IRELAND - Jan 16, 2018 - Dublin, Ireland – January 16th, 2018 –Aalto Bio Reagents is pleased to announce availability of its new mouse monoclonal antibody to Helicobacter pylori flagellin for diagnostic test manufacturers, vaccine developers and researchers globallyFull story -
Bioinformatics firm Mind the Byte acquires Intelligent Pharma
Jan 16, 2018, 06:34 AM by Michael CroftBARCELONA, SPAIN - Jan 16, 2018 - Bioinformatics firm Mind the Byte, a pioneer in the development of technologies based on artificial intelligence, cloud and big data for computational drug design, has acquired 100% of Intelligent Pharma, one of the leaders in Spain in chemoinformatics services for the pharmaceutical and biotechnology industryFull story -
DNA Sequencing Holds Some Promise For Treating Tumors
Jan 15, 2018, 16:08 PM by Michael CroftNPR | Sequencing the DNA of cancer tumors to help pinpoint treatment is an emerging element of precision medicine. While patients and doctors alike want these tests, they often don't benefit patients.Full story -
23andMe CEO Goes Beyond “Wall Of A White Coat”
Jan 15, 2018, 12:55 PM by Michael CroftFull storyBio-IT World | Speaking at the 36th annual JP Morgan Healthcare Conference, 23andMe’s CEO and co-founder Anne Wojcicki reflected on the scope of the 23andMe’s dataset, especially as it pertains to healthcare and drug discovery.
-
Meditraq launches to simplify serialisation data challenge
Jan 15, 2018, 11:44 AM by Michael CroftETTEN-LEUR, NETHERLANDS - Jan 15, 2018 - A new serialisation implementation partner has formed to assist the increasing number of companies needing to meet the data requirements of looming global regulation changesFull story -
JP Morgan 2018 News Roundup
Jan 12, 2018, 13:35 PM by Michael CroftFull storyBio-IT World | The 36th annual JP Morgan Healthcare Conference was held this week in San Francisco, bringing together more than 400 companies to showcase their growth and innovation. Here are some of the highlights and announcements we’ve collected from the conference.
-
Nonprofit Price For New Childhood Blindness Therapy 4X Too High
Jan 12, 2018, 12:22 PM by Michael CroftSTAT | Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.Full story -
BioIVT Launches Scientific Advisory Board, Expands Drug Development Expertise
Jan 11, 2018, 10:23 AM by Michael CroftWESTBURY, NY - Jan 11, 2018 - BioIVT, a leading provider of biospecimens and related services, today announced the launch of its BioIVT Scientific Advisory Board (SAB)Full story -
MDI Biological Laboratory Discovery Could Lead to New Therapies for Diabetics
Jan 10, 2018, 16:42 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Jan 10, 2018 - New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetesFull story -
TARGET PharmaSolutions to advance NASH Research through New Collaboration
Jan 10, 2018, 10:46 AM by Michael CroftCHAPEL HILL, NC - Jan 10, 2018 - TARGET PharmaSolutions, Inc., a real-world data solutions company, is pleased to announce that Novartis has entered into a long-term strategic alliance for TARGET-NASHFull story -
Genedata Screener Raises the Bar on Automation in 2018
Jan 9, 2018, 10:09 AM by Michael CroftBASEL, SWITZERLAND - Jan 9, 2018 - Genedata, a leading provider of advanced software solutions for R&D, today announced that Genedata Screener® has been enhanced towards full automation of the planning, execution, and data analysis of screening experimentsFull story -
BC Platforms to Provide Big Data Driven Research Solutions to Amgen in Cardiovascular Diseases and Oncology
Jan 9, 2018, 02:18 AM by Michael CroftBASEL, SWITZERLAND - Jan 9, 2018 - BC Platforms, a world leader in genomic data management and analysis solutions, today announces that Amgen Finland will be using its technology solutions and research platform, including Full storyCreative Diagnostics Launches Epigenetics Antibodies for Bio-research Communities
Jan 8, 2018, 22:34 PM by Michael CroftSHIRLEY, NY - Jan 9, 2018 - As a leading supplier of high quality antibodies validated for use in multiplexed assays, Creative Diagnostics recently launches epigenetics antibodies to global academic, pharmaceutical and biotech communities for specific and reproducible epigenetic target detectionFull storyIllumina Announces iSeq 100, Thermo Fisher Partnership
Jan 8, 2018, 21:30 PM by Michael CroftBio-IT World In the company’s JP Morgan presentation today, Illumina president and CEO Francis deSouza summarized the past year for the sequencing giant, highlighted expected areas of growth—consumer genomics, non-invasive prenatal testing—and announced the launch of the iSeq 100 Sequencing System and library prep partnership with Thermo Fisher.Full storyGenomics England Uses DRAGEN Pipeline To Re-Analyze 5000 Whole Genomes
Jan 8, 2018, 09:35 AM by Michael CroftBio-IT World Brief Genomics England is currently using Edico Genome’s DRAGEN analysis pipeline to re-process 5,000 whole human genomes from individuals with rare diseases. Genomics England and Edico announced the partnership today at the annual J.P. Morgan Healthcare Conference.Full storySYGNIS AG launches TruePrime™ apoptotic cell free DNA amplification kit for the liquid biopsy market
Jan 8, 2018, 07:48 AM by Michael Croft, HEIDELBERG, GERMANY AND CAMBRIDGE, UK - Dec 6, 2017 - SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and CFull storyAt Least Three Billion Computer Chips Have the Spectre Security Hole
Jan 5, 2018, 15:42 PM by Michael CroftMIT Technology Review | Tech companies are still working overtime on patching two critical vulnerabilities in computer chips that were revealed this week.Full storyFoxconn Builds Taiwan’s Largest Supercomputer
Jan 5, 2018, 10:40 AM by Michael CroftTOP500 | A six-petaflop system has been installed at Taiwan's Kaohsiung Software Technology Park, making it the most powerful supercomputer in the country.Full story